nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3B—eye—age related macular degeneration	0.0567	0.221	CbGeAlD
Lithium—GSK3B—connective tissue—age related macular degeneration	0.0546	0.213	CbGeAlD
Lithium—GSK3B—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0523	0.0704	CbGpPWpGaD
Lithium—GSK3A—eye—age related macular degeneration	0.0493	0.192	CbGeAlD
Lithium—IMPA1—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.049	0.066	CbGpPWpGaD
Lithium—GSK3A—retina—age related macular degeneration	0.0488	0.19	CbGeAlD
Lithium—GSK3A—connective tissue—age related macular degeneration	0.0475	0.185	CbGeAlD
Lithium—GSK3B—LKB1 signaling events—MAP2—age related macular degeneration	0.0382	0.0514	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.0275	0.037	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—COL10A1—age related macular degeneration	0.021	0.0282	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.0185	0.0248	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.0172	0.0231	CbGpPWpGaD
Lithium—GSK3B—Melatonin metabolism and effects—APOE—age related macular degeneration	0.0154	0.0207	CbGpPWpGaD
Lithium—IMPA2—Metabolism—NMNAT1—age related macular degeneration	0.0138	0.0186	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.0136	0.0183	CbGpPWpGaD
Lithium—IMPA1—Metabolism—NMNAT1—age related macular degeneration	0.0123	0.0166	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ELOVL4—age related macular degeneration	0.0121	0.0163	CbGpPWpGaD
Lithium—GSK3B—IL-6 signaling pathway—CRP—age related macular degeneration	0.0115	0.0154	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ELOVL4—age related macular degeneration	0.0108	0.0145	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.0104	0.0139	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00984	0.0132	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00984	0.0132	CbGpPWpGaD
Lithium—IMPA2—Metabolism—SLC16A8—age related macular degeneration	0.00974	0.0131	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00961	0.0129	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00956	0.0129	CbGpPWpGaD
Lithium—GSK3B—Cardiac Progenitor Differentiation—KDR—age related macular degeneration	0.00929	0.0125	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—SQSTM1—age related macular degeneration	0.00928	0.0125	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—C9—age related macular degeneration	0.00901	0.0121	CbGpPWpGaD
Lithium—IMPA1—Metabolism—SLC16A8—age related macular degeneration	0.00868	0.0117	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00859	0.0116	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00797	0.0107	CbGpPWpGaD
Lithium—GSK3A—Unfolded Protein Response (UPR)—CCL2—age related macular degeneration	0.00792	0.0107	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CFI—age related macular degeneration	0.00781	0.0105	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CFHR3—age related macular degeneration	0.00726	0.00977	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00721	0.0097	CbGpPWpGaD
Lithium—GSK3B—Alzheimers Disease—APOE—age related macular degeneration	0.00689	0.00928	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—CST3—age related macular degeneration	0.00678	0.00913	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—C9—age related macular degeneration	0.00666	0.00896	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—C2—age related macular degeneration	0.00647	0.00871	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00634	0.00854	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—TLR4—age related macular degeneration	0.00598	0.00805	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CFI—age related macular degeneration	0.00577	0.00777	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—SQSTM1—age related macular degeneration	0.00564	0.00758	CbGpPWpGaD
Lithium—GSK3A—Disease—NMNAT1—age related macular degeneration	0.00554	0.00746	CbGpPWpGaD
Lithium—GSK3A—Disease—RDH8—age related macular degeneration	0.00554	0.00746	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CFH—age related macular degeneration	0.00541	0.00728	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CFHR3—age related macular degeneration	0.00536	0.00722	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CFB—age related macular degeneration	0.00525	0.00706	CbGpPWpGaD
Lithium—GSK3A—Immune System—C9—age related macular degeneration	0.00525	0.00706	CbGpPWpGaD
Lithium—IMPA2—Metabolism—LIPC—age related macular degeneration	0.00499	0.00671	CbGpPWpGaD
Lithium—GSK3A—Disease—RPE65—age related macular degeneration	0.00484	0.00652	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CETP—age related macular degeneration	0.00481	0.00648	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—C2—age related macular degeneration	0.00478	0.00643	CbGpPWpGaD
Lithium—GSK3A—Immune System—CFI—age related macular degeneration	0.00455	0.00612	CbGpPWpGaD
Lithium—IMPA1—Metabolism—LIPC—age related macular degeneration	0.00445	0.00598	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CETP—age related macular degeneration	0.00429	0.00577	CbGpPWpGaD
Lithium—GSK3A—Immune System—CFHR3—age related macular degeneration	0.00423	0.00569	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—SQSTM1—age related macular degeneration	0.00416	0.0056	CbGpPWpGaD
Lithium—GSK3B—Disease—NMNAT1—age related macular degeneration	0.00409	0.00551	CbGpPWpGaD
Lithium—GSK3B—Disease—RDH8—age related macular degeneration	0.00409	0.00551	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CFH—age related macular degeneration	0.004	0.00538	CbGpPWpGaD
Lithium—GSK3A—Disease—ABCA4—age related macular degeneration	0.0039	0.00525	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RDH8—age related macular degeneration	0.00388	0.00522	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CFB—age related macular degeneration	0.00388	0.00522	CbGpPWpGaD
Lithium—GSK3B—Immune System—C9—age related macular degeneration	0.00388	0.00522	CbGpPWpGaD
Lithium—GSK3A—Immune System—C2—age related macular degeneration	0.00377	0.00507	CbGpPWpGaD
Lithium—GSK3B—Disease—RPE65—age related macular degeneration	0.00358	0.00482	CbGpPWpGaD
Lithium—GSK3A—Disease—RHO—age related macular degeneration	0.0034	0.00457	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RPE65—age related macular degeneration	0.00339	0.00456	CbGpPWpGaD
Lithium—GSK3B—Immune System—CFI—age related macular degeneration	0.00336	0.00452	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—KDR—age related macular degeneration	0.00335	0.0045	CbGpPWpGaD
Lithium—GSK3A—Immune System—CFH—age related macular degeneration	0.00315	0.00424	CbGpPWpGaD
Lithium—GSK3B—Immune System—CFHR3—age related macular degeneration	0.00312	0.0042	CbGpPWpGaD
Lithium—GSK3A—Immune System—CFB—age related macular degeneration	0.00306	0.00411	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.003	0.00404	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CD36—age related macular degeneration	0.00289	0.00389	CbGpPWpGaD
Lithium—GSK3B—Disease—ABCA4—age related macular degeneration	0.00288	0.00388	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RDH8—age related macular degeneration	0.00287	0.00386	CbGpPWpGaD
Lithium—GSK3B—Immune System—C2—age related macular degeneration	0.00278	0.00375	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ABCA4—age related macular degeneration	0.00273	0.00368	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CD36—age related macular degeneration	0.00258	0.00347	CbGpPWpGaD
Lithium—IMPA2—Metabolism—APOE—age related macular degeneration	0.00255	0.00343	CbGpPWpGaD
Lithium—GSK3B—Disease—RHO—age related macular degeneration	0.00251	0.00338	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RPE65—age related macular degeneration	0.00251	0.00337	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00248	0.00334	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RHO—age related macular degeneration	0.00238	0.0032	CbGpPWpGaD
Lithium—GSK3B—Immune System—CFH—age related macular degeneration	0.00233	0.00313	CbGpPWpGaD
Lithium—IMPA1—Metabolism—APOE—age related macular degeneration	0.00227	0.00306	CbGpPWpGaD
Lithium—GSK3B—Immune System—CFB—age related macular degeneration	0.00226	0.00304	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—KDR—age related macular degeneration	0.00218	0.00294	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD36—age related macular degeneration	0.00215	0.0029	CbGpPWpGaD
Lithium—GSK3A—Disease—CST3—age related macular degeneration	0.00212	0.00286	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD36—age related macular degeneration	0.00207	0.00278	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—C3—age related macular degeneration	0.00204	0.00275	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ABCA4—age related macular degeneration	0.00202	0.00272	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—C3—age related macular degeneration	0.00196	0.00264	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CRP—age related macular degeneration	0.00194	0.00261	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFBR1—age related macular degeneration	0.00191	0.00257	CbGpPWpGaD
Lithium—GSK3A—Immune System—SQSTM1—age related macular degeneration	0.00187	0.00252	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TLR4—age related macular degeneration	0.00186	0.00251	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—VEGFA—age related macular degeneration	0.00184	0.00248	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CD36—age related macular degeneration	0.0018	0.00243	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RHO—age related macular degeneration	0.00176	0.00236	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD36—age related macular degeneration	0.00159	0.00214	CbGpPWpGaD
Lithium—GSK3B—Disease—CST3—age related macular degeneration	0.00157	0.00211	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—KDR—age related macular degeneration	0.00156	0.0021	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD36—age related macular degeneration	0.00153	0.00206	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—C3—age related macular degeneration	0.00151	0.00203	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—C3—age related macular degeneration	0.00145	0.00195	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CRP—age related macular degeneration	0.00144	0.00193	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—VEGFA—age related macular degeneration	0.00142	0.00191	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFBR1—age related macular degeneration	0.00141	0.0019	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CCL2—age related macular degeneration	0.0014	0.00188	CbGpPWpGaD
Lithium—GSK3B—Immune System—SQSTM1—age related macular degeneration	0.00138	0.00186	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TLR4—age related macular degeneration	0.00138	0.00185	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00134	0.0018	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD36—age related macular degeneration	0.00126	0.00169	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SQSTM1—age related macular degeneration	0.00121	0.00163	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—VEGFA—age related macular degeneration	0.0012	0.00162	CbGpPWpGaD
Lithium—GSK3A—Immune System—C3—age related macular degeneration	0.00119	0.0016	CbGpPWpGaD
Lithium—GSK3A—Immune System—CRP—age related macular degeneration	0.00113	0.00152	CbGpPWpGaD
Lithium—GSK3A—Immune System—TLR4—age related macular degeneration	0.00108	0.00146	CbGpPWpGaD
Lithium—GSK3A—Disease—APOE—age related macular degeneration	0.00102	0.00138	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000987	0.00133	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD36—age related macular degeneration	0.000927	0.00125	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000894	0.0012	CbGpPWpGaD
Lithium—GSK3B—Immune System—C3—age related macular degeneration	0.000879	0.00118	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—VEGFA—age related macular degeneration	0.000859	0.00116	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—age related macular degeneration	0.000836	0.00113	CbGpPWpGaD
Lithium—GSK3B—Immune System—TLR4—age related macular degeneration	0.000802	0.00108	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—C3—age related macular degeneration	0.000769	0.00103	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—age related macular degeneration	0.000755	0.00102	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—age related macular degeneration	0.000716	0.000963	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KDR—age related macular degeneration	0.000701	0.000944	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL2—age related macular degeneration	0.000602	0.00081	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—C3—age related macular degeneration	0.000568	0.000765	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—age related macular degeneration	0.000529	0.000712	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KDR—age related macular degeneration	0.000518	0.000697	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL2—age related macular degeneration	0.000445	0.000598	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VEGFA—age related macular degeneration	0.000386	0.00052	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VEGFA—age related macular degeneration	0.000286	0.000384	CbGpPWpGaD
